BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 16768726)

  • 21. Donor-derived IP-10 initiates development of acute allograft rejection.
    Hancock WW; Gao W; Csizmadia V; Faia KL; Shemmeri N; Luster AD
    J Exp Med; 2001 Apr; 193(8):975-80. PubMed ID: 11304558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human eosinophils produce the T cell-attracting chemokines MIG and IP-10 upon stimulation with IFN-gamma.
    Dajotoy T; Andersson P; Bjartell A; Löfdahl CG; Tapper H; Egesten A
    J Leukoc Biol; 2004 Sep; 76(3):685-91. PubMed ID: 15197236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunotherapy with interleukin-10 depends on the CXC chemokines inducible protein-10 and monokine induced by IFN-gamma.
    Dorsey R; Kundu N; Yang Q; Tannenbaum CS; Sun H; Hamilton TA; Fulton AM
    Cancer Res; 2002 May; 62(9):2606-10. PubMed ID: 11980656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CXC and CC chemokines induced in human renal epithelial cells by inflammatory cytokines.
    Thorburn E; Kolesar L; Brabcova E; Petrickova K; Petricek M; Jaresova M; Slavcev A; Striz I
    APMIS; 2009 Jul; 117(7):477-87. PubMed ID: 19594487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The chemokine and chemokine receptor profile of infiltrating cells in the wall of arteries with cardiac allograft vasculopathy is indicative of a memory T-helper 1 response.
    van Loosdregt J; van Oosterhout MF; Bruggink AH; van Wichen DF; van Kuik J; de Koning E; Baan CC; de Jonge N; Gmelig-Meyling FH; de Weger RA
    Circulation; 2006 Oct; 114(15):1599-607. PubMed ID: 17015796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune mechanisms associated with the rejection of encapsulated neonatal porcine islet xenografts.
    Kobayashi T; Harb G; Rajotte RV; Korbutt GS; Mallett AG; Arefanian H; Mok D; Rayat GR
    Xenotransplantation; 2006 Nov; 13(6):547-59. PubMed ID: 17059582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR.
    Mapara MY; Leng C; Kim YM; Bronson R; Lokshin A; Luster A; Sykes M
    Biol Blood Marrow Transplant; 2006 Jun; 12(6):623-34. PubMed ID: 16737935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the chemokines IP-10 and Mig in IL-10 transduced tumors.
    Sun H; Kundu N; Dorsey R; Jackson MJ; Fulton AM
    J Immunother; 2001; 24(2):138-43. PubMed ID: 11265771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of CXCR3 and CCR5 in allograft rejection.
    Schnickel GT; Hsieh GR; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
    Transplant Proc; 2006 Dec; 38(10):3221-4. PubMed ID: 17175228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TNF-alpha is a potent inducer for IFN-inducible protein-10 in hepatocytes and unaffected by GM-CSF in vivo, in contrast to IL-1beta and IFN-gamma.
    Narumi S; Yoneyama H; Inadera H; Nishioji K; Itoh Y; Okanoue T; Matsushima K
    Cytokine; 2000 Jul; 12(7):1007-16. PubMed ID: 10880246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interferon-gamma and CXC chemokine induction by interleukin 12 in renal cell carcinoma.
    Bukowski RM; Rayman P; Molto L; Tannenbaum CS; Olencki T; Peereboom D; Tubbs R; McLain D; Budd GT; Griffin T; Novick A; Hamilton TA; Finke J
    Clin Cancer Res; 1999 Oct; 5(10):2780-9. PubMed ID: 10537342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice.
    Keino H; Takeuchi M; Kezuka T; Yamakawa N; Tsukahara R; Usui M
    Graefes Arch Clin Exp Ophthalmol; 2003 Feb; 241(2):111-5. PubMed ID: 12605265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between islet xenograft rejection mediated by activated macrophages and upregulated chemokines.
    Chandra AP; Ou-Yang L; Wong JK; Ha H; Walters SN; Patel AT; Hawthorne WJ; Yi SN
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):26-35. PubMed ID: 17344583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor.
    Tannenbaum CS; Tubbs R; Armstrong D; Finke JH; Bukowski RM; Hamilton TA
    J Immunol; 1998 Jul; 161(2):927-32. PubMed ID: 9670971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unique gene expression profiles of heart allograft rejection in the interferon regulatory factor-1-deficient mouse.
    Erickson L; Crews G; Pan F; Fisniku O; Jang MS; Wynn C; Kobayashi M; Jiang H
    Transpl Immunol; 2004 Nov; 13(3):169-75. PubMed ID: 15381199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chlamydophila pneumoniae induces production of the defensin-like MIG/CXCL9, which has in vitro antichlamydial activity.
    Balogh EP; Faludi I; Virók DP; Endrész V; Burián K
    Int J Med Microbiol; 2011 Mar; 301(3):252-9. PubMed ID: 21056004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapamycin treatment depresses intragraft expression of KC/MIP-2, granzyme B, and IFN-gamma in rat recipients of cardiac allografts.
    Wieder KJ; Hancock WW; Schmidbauer G; Corpier CL; Wieder I; Kobzik L; Strom TB; Kupiec-Weglinski JW
    J Immunol; 1993 Jul; 151(2):1158-66. PubMed ID: 8335897
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of CXCL-1/KC production in high risk vascularized corneal allografts on T cell recruitment and graft rejection.
    Amescua G; Collings F; Sidani A; Bonfield TL; Rodriguez JP; Galor A; Medina C; Yang X; Perez VL
    Transplantation; 2008 Feb; 85(4):615-25. PubMed ID: 18347542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IP-10-induced recruitment of CXCR3 host T cells is required for small bowel allograft rejection.
    Zhang Z; Kaptanoglu L; Tang Y; Ivancic D; Rao SM; Luster A; Barrett TA; Fryer J
    Gastroenterology; 2004 Mar; 126(3):809-18. PubMed ID: 14988835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes.
    Kawada K; Sonoshita M; Sakashita H; Takabayashi A; Yamaoka Y; Manabe T; Inaba K; Minato N; Oshima M; Taketo MM
    Cancer Res; 2004 Jun; 64(11):4010-7. PubMed ID: 15173015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.